A detailed history of Point72 (Difc) LTD transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Point72 (Difc) LTD holds 77 shares of AADI stock, worth $175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
77
Previous 4,888 98.42%
Holding current value
$175
Previous $7.14 Million 97.77%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.32 - $2.06 $6,350 - $9,910
-4,811 Reduced 98.42%
77 $159,000
Q2 2024

Aug 14, 2024

BUY
$1.46 - $2.31 $7,136 - $11,291
4,888 New
4,888 $7.14 Million

Others Institutions Holding AADI

About Aadi Bioscience, Inc.


  • Ticker AADI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,016,800
  • Market Cap $47.9M
  • Description
  • Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...
More about AADI
Track This Portfolio

Track Point72 (Difc) LTD Portfolio

Follow Point72 (Difc) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 (Difc) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 (Difc) LTD with notifications on news.